Figure 2
![Figure 2. Time to pCR of HP-eradicated patients. Time was calculated from the completion of antibiotic treatment to first evidence of pCR by Kaplan-Meier analysis (pure [de novo] DLBCL vs DLBCL[MALT]; P = .024, 2-sided, log-rank test).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/119/21/10.1182_blood-2012-01-404194/4/zh89991289910002.jpeg?Expires=1722546567&Signature=wC4-DpBV2cPs9F9Gw9zZ32iYdIYIBesCKAdDHpgVJ5k67~UF97Jk6V-5IcuCmwTIih3aSmvxQ3yI7Gy7ZYTQ5SGxLZ3tg2AJ7Po9UGUUCHDah7S-dxgMdQa-O2tUWT5~AiXSXKbhr2WzhUZJrFpZFbwgmnZmmKbIwqLOeys~SP~7tZ48Xkd0X4HZBLi1ieJD7A3vE1fyncxGMFdxE6X~L1ullyh~Nb920LkvBKHwnHwy6O9YCFsdyAKYyQwOO1VAv520uoBcxv9QkqIPaLaIItmSEKDAVi5OtMiGhks3juyRzmCvyzyyzCMHjmD680BG6dzkm5u~8CCIfPj~bdICzg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Time to pCR of HP-eradicated patients. Time was calculated from the completion of antibiotic treatment to first evidence of pCR by Kaplan-Meier analysis (pure [de novo] DLBCL vs DLBCL[MALT]; P = .024, 2-sided, log-rank test).
Time to pCR of HP-eradicated patients. Time was calculated from the completion of antibiotic treatment to first evidence of pCR by Kaplan-Meier analysis (pure [de novo] DLBCL vs DLBCL[MALT]; P = .024, 2-sided, log-rank test).
